share_log

Cantor Fitzgerald Downgrades Aravive to Neutral, Lowers Price Target to $0.25

Cantor Fitzgerald Downgrades Aravive to Neutral, Lowers Price Target to $0.25

坎托·菲茨杰拉德将Aravive的评级下调至中性,将目标价下调至0.25美元
Benzinga ·  2023/08/22 07:56

Cantor Fitzgerald analyst Louise Chen downgrades Aravive (NASDAQ:ARAV) from Overweight to Neutral and lowers the price target from $18 to $0.25.

坎托·菲茨杰拉德分析师路易丝·陈将Aravive(纳斯达克股票代码:ARAV)的评级从增持下调至中性,并将目标股价从18美元下调至0.25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发